Supplements

Expanding Contraceptive Choices for Women: The Vaginal pH Modulator

This activity is supported by an independent educational grant from Evofem Biosciences.

 

Read Now.

Vaginal pH modulators (VPMs) add a new class of contraception that is now available in the United States. This method is nonhormonal, woman-controlled, and coitally dependent—and has the potential to increase overall contraceptive use and potentially reduce unintended pregnancy rates.

This CME supplement to OBG Management focuses on VPMs, their attributes, and the methodology surrounding the determination of contraceptive effectiveness.

Read Now.

Recommended Reading

Too many patient call messages
MDedge ObGyn
Low vitamin D in COVID-19 predicts ICU admission, poor survival
MDedge ObGyn
Physician reimbursement 2021: Who are the big winners?
MDedge ObGyn
Treat-to-target strategy ‘not ready for primetime’ in osteoporosis
MDedge ObGyn
Highlights from the 2020 Scientific Meeting of the Society of Gynecologic Surgeons
MDedge ObGyn
Observational study again suggests lasting impact of COVID-19 on heart
MDedge ObGyn
Without Ginsburg, judicial threats to the ACA, reproductive rights heighten
MDedge ObGyn
Three-step approach may help relieve one of the itchiest vulvar conditions
MDedge ObGyn
CDC adds then retracts aerosols as main COVID-19 mode of transmission
MDedge ObGyn
Longer bisphosphonate use ups AFF risk, but not all is tied to drug
MDedge ObGyn